Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-090-1 | CAS number: 103-23-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction: other studies
Administrative data
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Testicular toxicity of DEHP, but not DEHA, is elevated under conditions of thioacetamide-induced liver damage
- Author:
- Jin Seok Kang, Keiichirou Morimura, Chitose Toda, Hideki Wanibuchi, Min Wei, Nakao Kojima, Shoji Fukushima
- Year:
- 2 006
- Bibliographic source:
- Reproductive Toxicology 21 (2006) 253–259
Materials and methods
- Principles of method if other than guideline:
- As part of an investigation of possible enhancement by liver disease of testicular toxicity caused by phthalates, the effects of di(2-ethylhexyl)phthalate (DEHP) and di(2-ethylhexyl)adipate (DEHA) in a thioacetamide (TAA)-induced rat liver damage model were tested. Male, 6-week-old, F344 rats (n = 60) were divided into ten groups. Animals of groups 1–5 received TAA (200 mg/kg, intraperitoneal, three times per week) for 4 weeks, and groups 6–10 served as controls without TAA. After a 1 week interval, at week 5, powder diet containing DEHP or DEHA was provided to the animals of groups 1 and 6 (DEHP 25 000 ppm), groups 2 and 7 (DEHP 6000 ppm), groups 3 and 8 (DEHA 25 000 ppm) and groups 4 and 9 (DEHA 6000 ppm), while groups 5 and 10 received basal diet. All animals were sacrificed at week 9.
- GLP compliance:
- not specified
- Type of method:
- in vivo
Test material
- Reference substance name:
- Bis(2-ethylhexyl) adipate
- EC Number:
- 203-090-1
- EC Name:
- Bis(2-ethylhexyl) adipate
- Cas Number:
- 103-23-1
- Molecular formula:
- C22H42O4
- IUPAC Name:
- bis(2-ethylhexyl) adipate
Constituent 1
- Specific details on test material used for the study:
- DEHP (>99.5%), purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Sixty, 5-week-old, male F344 rats were obtained from Charles River Japan Inc. (Atsugi, Japan), and housed in rooms maintained on a 12 h light/dark cycle, at constant temperature and humidity. They were allowed free access to MF powder diets (Oriental Yeast Co., Tokyo, Japan) during the experiment. All procedures were approved by the Institutional Animal Care and Use Committee of Osaka City University Medical School.
Administration / exposure
- Route of administration:
- oral: feed
- Details on exposure:
- At 6 weeks of age, the rats were divided into ten groups (six rats per group). Animals of groups 1–5 were treated with TAA (200 mg/kg, intraperitoneal, three times per week) dissolved in phosphate buffered saline (PBS) for 4 weeks, and those of groups 6–10 received PBS alone without TAA. After a 1 week interval, at week 5, powder diet containing DEHP or DEHA was provided to the animals of groups 1 and 6 (DEHP 25 000 ppm), groups 2 and 7 (DEHP 6000 ppm), groups 3 and 8 (DEHA 25 000 ppm) and groups 4 and 9 (DEHA 6000 ppm), while groups 5 and 10 received basal diet.
- Details on study design:
- Body weights were measured every week and all animals were sacrificed at week 9 under ether anesthesia. At necropsy, blood samples were collected from the abdominal vein for measurement of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transpeptidase (g-GTP). The organs of interest (liver,testes, epididymes, prostates, seminal vesicles) were measured, resected and processed.For the investigation of spermatogenesis, the testes and epididymes were removed. Sperm head counts were determined by methods as a previous report with some modification. In briefly, the right testes were homogenized (Politoron-TP20, Politron, Switzerland) for 1 min in 10mL water and counts of sperm heads were made in 1 mL chambers (Kova® Glasstic® Slide 10 with grids, Hycor Biomedical Inc., USA) under a microscope at 200× magnification. Sperm collected from the caudal epididymes were incubated in Medium 199 (with Hank’s salt, l-glutamine; Invitrogen) containing 1% bovine serum albumin (Calbiochem) at 37 ◦C for 5 min. Subsequently more than 100 sperms were assessment for sperm motility and for sperm morphology abnormalities by manual counting under a microscope at 200× and 400× magnification, respectively.
- Statistics:
- Statistical analyses were performed using the JMP program (SAS Institute, Cary, NC). For all comparisons, probability values less than 5% (p < 0.05) were considered to be statistically significant. The body weights, organ weights, sperm data, and metabolites data were analyzed by Bartlett’s test (significance concluded at the 5% level) for homogeneity of variance for mean values of each group following the decision tree mentioned below. Homogenous data in Bartlett’s test were subjected to the Tukey–Kramer test. Heterogenous data in Bartlett’s test were subjected to the Wilcoxon/Kruskal–Wallis and subjected to Dunnett test.
Results and discussion
Observed effects
Applicant's summary and conclusion
- Conclusions:
- DEHA did not show testicular toxicity in any group. The, hypertrophy of hepatocytes in livers has also been observed in other repeated dose studies with DEHA at high doses (e.g. Xu et al., 2019). However, this change was completely reversible with a recovery phase in other studies. It is therefore considered as non adverse.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.